Institution
Israel Ministry of Health
Government•Jerusalem, Israel•
About: Israel Ministry of Health is a government organization based out in Jerusalem, Israel. It is known for research contribution in the topics: Population & Public health. The organization has 1633 authors who have published 2108 publications receiving 65387 citations.
Topics: Population, Public health, Health care, Vaccination, Pregnancy
Papers published on a yearly basis
Papers
More filters
••
TL;DR: While patients with HSV ME had more manifestations of severe disease, there also was a significant overlap with clinical and laboratory parameters of VZV ME, confirming the prevalence of V zoster virus as a cause of sporadic ME over the last decade.
31 citations
••
Katholieke Universiteit Leuven1, University College Hospital, Ibadan2, Peking University3, Stony Brook University4, Universidade Federal do Espírito Santo5, St George's Hospital6, Harvard University7, University of Paris8, Leipzig University9, Israel Ministry of Health10, Utrecht University11, United States Department of Health and Human Services12, Ulster University13, Universidade Nova de Lisboa14, University of Barcelona15
TL;DR: Dose-response associations were found between number of indicators of need and treatment and the vast majority of treatment in the WMH countries goes to patients with mental disorders or other problems expected to benefit from treatment.
Abstract: Background
Previous research suggests that many people receiving mental health treatment do not meet criteria for a mental disorder but are rather ‘the worried well’.
Aims
To examine the association of past-year mental health treatment with DSM-IV disorders.
Method
The World Health Organization’s World Mental Health (WMH) Surveys interviewed community samples of adults in 23 countries ( n = 62 305) about DSM-IV disorders and treatment in the past 12 months for problems with emotions, alcohol or drugs.
Results
Roughly half (52%) of people who received treatment met criteria for a past-year DSM-IV disorder, an additional 18% for a lifetime disorder and an additional 13% for other indicators of need (multiple subthreshold disorders, recent stressors or suicidal behaviours). Dose-response associations were found between number of indicators of need and treatment.
Conclusions
The vast majority of treatment in the WMH countries goes to patients with mental disorders or other problems expected to benefit from treatment.
31 citations
••
TL;DR: The trend toward increased risk after a short time lapse and the difference in risk among immigrants indicate that genetic susceptibility is part of the complex interplay between cellular proliferation and control systems.
Abstract: Although the incidence of classic Kaposi's sarcoma (CKS) has been investigated, its occurrence following a primary neoplasm and its association with this first neoplasm need to be determined. We analyzed a series of 124 patients with a secondary CKS (8.4% of a total of 1485 incident cases) which occurred between 1961 and 1992 in the Jewish Israeli population. Data on first neoplasms and subsequent Kaposi's sarcoma were retrieved from the Israel Cancer Registry. Acquired-immune-deficiency-syndrome-related Kaposi's sarcomas were excluded from the case series. Four controls were randomly selected for each CKS case among all Cancer Registry cases free from a second neoplasm at the time of diagnosis of the CKS in the case, and matched on gender, year of birth and year of diagnosis of the first neoplasm. The average time lapse between first neoplasm and secondary CKS was 4.5 years, being shorter for prostate cancer and for hematopoietic malignancies. As compared with Israel-born Jews, the risk of a subsequent CKS was significantly increased in immigrants [odds ratio (OR) 3.0]; this risk was particularly high in immigrants from the former Soviet Union (OR 9.4) and Poland (OR 7.0). There was no clear trend with age at immigration; however, low age at immigration and a short length of stay in Israel endowed a higher risk of developing a secondary CKS, markedly among patients suffering from solid tumors as the first primary. There was an excess of secondary CKS following a non-Hodgkin's lymphoma (OR 5.3), a Hodgkin's lymphoma (OR 7.5), a leukemia (OR 5.3) or a breast cancer (OR 2.2). Cancer patients with a first primary in the lung, colon, stomach, larynx, liver, pancreas or kidney showed secondary CKS less frequently. Despite the lack of control of therapy for the first neoplasm, development of secondary CKS seems to be mediated by mechanisms similar to those for hematopoietic neoplasms and selected nonhematopoietic neoplasms, such as breast cancer. The trend toward increased risk after a short time lapse and the difference in risk among immigrants indicate that genetic susceptibility is part of the complex interplay between cellular proliferation and control systems.
31 citations
••
TL;DR: The results indicate that ESBL-PE colonization is common upon admission to rehabilitation centres and the high prevalence and low ability to stratify by risk factors may guide infection control and empirical treatment strategies in rehabilitation settings.
31 citations
••
TL;DR: In this article, a management model was defined and tested towards optimal polishing of secondary effluent for agricultural irrigation using micro-filtration and reverse osmosis (RO) technology.
Abstract: Extra treatment stages are required to polish the secondary effluent for unrestricted reuse, primarily for agricultural irrigation. Improved technology for the removal of particles, turbidity, bacteria and cysts, without the use of disinfectants is based on MicroFiltration (MF) and UltraFiltration (UF) membrane technology and in series with Reverse Osmosis (RO) for dissolved solids removal. Field experiments were conducted using a mobile UF and RO membrane pilot unit at a capacity of around 1.0 m3/hr. A management model was defined and tested towards optimal polishing of secondary effluent. The two major purposes of the management model are: (i) to delineate a methodology for economic assessment of optimal membrane technology implementation for secondary effluent upgrading for unrestricted use, and; (ii) to provide guidelines for optimal RO membrane selection in regards to the pretreatment stage. The defined linear model takes into account the costs of the feed secondary effluent, the UF pretreatment and the RO process. Technological constraints refer primarily to the longevity of the membrane and their performance. Final treatment cost (the objective function) includes investment, operation and maintenance expenses, UF pretreatment, RO treatment, post treatment and incentive for low salinity permeate use. The cost range of water for irrigation according to the model is between 15 and 42 US cents per m3.
31 citations
Authors
Showing all 1636 results
Name | H-index | Papers | Citations |
---|---|---|---|
Gideon Koren | 129 | 1994 | 81718 |
Yuman Fong | 125 | 865 | 63931 |
Jeffrey M. Hausdorff | 106 | 401 | 52287 |
Yehuda Carmeli | 88 | 351 | 37154 |
Aaron Cohen | 78 | 412 | 66543 |
Igor M. Sokolov | 69 | 673 | 20256 |
Asher Ornoy | 67 | 367 | 13274 |
Robert H. Belmaker | 65 | 436 | 19583 |
Adam P. Dicker | 65 | 502 | 16964 |
Hagit Cohen | 64 | 219 | 13079 |
Jose Bras | 60 | 187 | 20081 |
Moshe Kotler | 59 | 257 | 11376 |
Baruch Modan | 59 | 202 | 18447 |
Zvi Laron | 58 | 511 | 14532 |
Roz Shafran | 57 | 240 | 20092 |